No company matches — see all tickers
Julie Sawyer Montgomery succeeds Rainer Blair as CEO; Blair stays on to support the transition through March 2027.
Earlier-than-expected Masimo closing and stronger Q2 performance drive higher FY2026 adjusted EPS guidance
Masimo adds patient monitoring but raises debt and legal exposure; earnings rebound mainly reflects the absence of prior-year impairments.
Coverage: 10-K, 10-Q and 8-K filings filed since Jul 1, 2026.
Request longer coverage
Company data: Wikidata Q1159256
We read every message.
